Literature DB >> 19857110

Bilateral deepening of upper lid sulcus from topical bimatoprost therapy.

Jason C S Yam1, Nancy S Y Yuen, Clement W N Chan.   

Abstract

PURPOSE: To report a new adverse effect related to treatment with bimatoprost.
METHOD: Case report. A 43-year-old Asian female with bilateral glaucoma was noticed to have bilateral deepening of upper lid sulcus 3 months after beginning treatment with bimatoprost 0.03%.
RESULTS: Bimatoprost was discontinued due to cosmetic reasons, and there was improvement of the lid sulcus deepening bilaterally 4 weeks after stopping the drug.
CONCLUSIONS: Deepening of upper lid sulcus is one of the adverse effects related to treatment with bimatoprost. This effect may be more prominent in Asians who have relatively full upper lid sulcus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19857110     DOI: 10.1089/jop.2009.0019

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  16 in total

1.  Incidence of deepening of the upper eyelid sulcus after switching from latanoprost to bimatoprost.

Authors:  Makoto Aihara; Shiroaki Shirato; Rei Sakata
Journal:  Jpn J Ophthalmol       Date:  2011-09-28       Impact factor: 2.447

2.  Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.

Authors:  Mohd Shazli Draman; Fiona Grennan-Jones; Lei Zhang; Peter N Taylor; Tommy Kyaw Tun; John McDermott; Paul Moriarty; Daniel Morris; Carol Lane; Seamus Sreenan; Colin Dayan; Marian Ludgate
Journal:  Thyroid       Date:  2013-11-04       Impact factor: 6.568

3.  Anandamide-derived prostamide F2α negatively regulates adipogenesis.

Authors:  Cristoforo Silvestri; Andrea Martella; Neil J Poloso; Fabiana Piscitelli; Raffaele Capasso; Angelo Izzo; David F Woodward; Vincenzo Di Marzo
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

4.  Effectiveness of the ICare rebound tonometer in patients with overestimated intraocular pressure due to tight orbit syndrome.

Authors:  You Kyung Lee; Y K Lee; Ji Young Lee; J Y Lee; Jung Il Moon; J I Moon; Myoung Hee Park; M H Park
Journal:  Jpn J Ophthalmol       Date:  2014-08-29       Impact factor: 2.447

5.  In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytes.

Authors:  Hee Young Choi; Ji Eun Lee; Ji Woong Lee; Hyun Jun Park; Ji Eun Lee; Jae Ho Jung
Journal:  J Ocul Pharmacol Ther       Date:  2011-11-22       Impact factor: 2.671

6.  Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost.

Authors:  Rei Sakata; Shiroaki Shirato; Kazunori Miyata; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2012-12-13       Impact factor: 2.447

7.  Incidence of deepening of the upper eyelid sulcus on treatment with a tafluprost ophthalmic solution.

Authors:  Rei Sakata; Shiroaki Shirato; Kazunori Miyata; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2014-01-07       Impact factor: 2.447

8.  Incidence of deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy with a latanoprost ophthalmic solution.

Authors:  R Sakata; S Shirato; K Miyata; M Aihara
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

9.  Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma.

Authors:  Akira Sawada; Tetsuya Yamamoto; Naoyoshi Takatsuka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-21       Impact factor: 3.117

10.  Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases.

Authors:  Takaiko Yoshino; Takeo Fukuchi; Tetsuya Togano; Masaaki Seki; Hiroko Ikegaki; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2012-12-04       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.